August 19, 2023

CHIP and CCUS, Precursors to MDS

There have been marked developments in the understanding of clonal hematopoiesis based on findings of somatic mutations in genes known to be associated with MDS. This has led to newer terms to describe precursor states to MDS, such as clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). This webinar will provide an overview of these conditions which may allow earlier diagnosis, modify surveillance for MDS, and guide additional therapies.

Speaker

ZX

Zhuoer Xie, MD, MS

Our Supporters

Thank you to AbbVie, Bristol-Myers Squibb, Gilead, Jazz Pharmaceuticals, Taiho Oncology, and VJHemonc for supporting this initiative.

The MDS Foundation proudly partners with the following organizations

MDS AllianceKnow AMLALAN

Get in touch

Email

patientliaison@mds-foundation.org
hcp@mds-foundation.org

Phone within the US

1-(800)-637-0839

Outside the US only

1-(609)-298-1035

Address

The MDS Foundation
4573 South Broad St., Suite 150
Yardville, NJ 08620

Guide Star Platinum

A global non-profit advocacy organization, supporting patients, families and healthcare providers in the fields of MDS and its related diseases for over 30 years

© 2024 MDS Foundation. All rights reserved.